Episode 18: Among the topics: Management of left ventricular thrombus - Diagnosis and treatment of HFpEF

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

This episode covers:

• Cardiology This Week: A concise summary of recent studies
• Management of left ventricular thrombus
• Diagnosis and treatment of HFpEF – State of the art in 2023
• Diagnostics Made Easy: Constriction vs. restriction in echocardiography

Host: Rick Grobbee

Guests: Glenn Levine and Theresa McDonagh

Want to watch that episode? Go to: https://esc365.escardio.org/event/1083

 

Disclaimer

This programme is supported by Siemens Healthineers in the form of an educational grant. The scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor.

This programme is intended for health care professionals only and is to be used for educational purposes.

The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

 

Declarations of interests

Stephan Achenbach, Rick Grobbee, Nicolle Kraenkel, Glenn Levine and Theresa McDonagh have declared to have no potential conflicts of interest to report.

Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.

Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.